News & Blog

Defeat Pediatric Brain Tumors Research Collaborative: 2018 Progress Update and 2019 Work in Progress

The Defeat Pediatric Brain Tumors Research Collaborative has brought together some of the world’s best pediatric brain tumor research teams from St. Jude Children’s Research Hospital, Montreal Children’s Hospital/McGill University Health Centre, and the German Cancer Research Center to work in a team environment and share data and other resources to speed the scientific discovery […]

Can Newly Approved “Tissue Agnostic” Drugs Benefit Pediatric High-grade Glioma Patients?

Recently, the U.S. Food and Drug Administration (FDA) granted accelerated approval* to the drug Rozlytrek (entrectinib, Genentech/Roche**) as a treatment for patients, 12 years or older, whose tumors have a specific genetic defect known as an “NTRK gene fusion.”*** This is now the second drug that the FDA has approved to treat patients with this […]

Gliogene: Confronting the Unknown Through Research

As the saying goes, knowledge is power. But, sometimes, it can also be scary. “Oh, it’s horrible!” says Carrie Davis about her quest, which she shares with her sister Hadley, to help better understand links between inheritable genes and brain tumors. She continues, “Every time I get a headache I think I have a brain […]

Share